Skip to main content
The Journal of Biological Chemistry logoLink to The Journal of Biological Chemistry
. 2013 Jan 3;288(8):5928–5939. doi: 10.1074/jbc.M112.434357

Structure of the Type VI Effector-Immunity Complex (Tae4-Tai4) Provides Novel Insights into the Inhibition Mechanism of the Effector by Its Immunity Protein*

Heng Zhang ‡,1, Heng Zhang §,1, Zeng-Qiang Gao §, Wen-Jia Wang §, Guang-Feng Liu §, Jian-Hua Xu §, Xiao-Dong Su ‡,2, Yu-Hui Dong §,3
PMCID: PMC3581433  PMID: 23288853

Background: The bacteria effector Tae4 is injected into the recipient cells to kill them and the immunity protein Tai4 is produced to inactivate Tae4.

Results: Tae4 displays a papain-like fold, and Tai4 dimer is responsible for inhibiting Tae4 activity.

Conclusion: The inactivation of Tae4 is required by collaboration of both subunits of Tai4 dimer.

Significance: Our results add new insights into the effector-immunity interaction module.

Keywords: Immunology, Microbial Pathogenesis, Protein Complexes, Protein Structure, Toxins, Tae4-Tai4 Complex Structure, Tai4 Dimerization, Effector-Immunity Pair, Type VI secretion system (T6SS)

Abstract

The type VI secretion system (T6SS), a multisubunit needle-like apparatus, has recently been found to play a role in interspecies interactions. The Gram-negative bacteria harboring T6SS (donor) deliver the effectors into their neighboring cells (recipient) to kill them. Meanwhile, the cognate immunity proteins were employed to protect the donor cells against the toxic effectors. Tae4 (type VI amidase effector 4) and Tai4 (type VI amidase immunity 4) are newly identified T6SS effector-immunity pairs. Here, we report the crystal structures of Tae4 from Enterobacter cloacae and Tae4-Tai4 complexes from both E. cloacae and Salmonella typhimurium. Tae4 acts as a dl-endopeptidase and displays a typical N1pC/P60 domain. Unlike Tsi1 (type VI secretion immunity 1), Tai4 is an all-helical protein and forms a dimer in solution. The small angle x-ray scattering study combined with the analytical ultracentrifugation reveal that the Tae4-Tai4 complex is a compact heterotetramer that consists of a Tai4 dimer and two Tae4 molecules in solution. Structure-based mutational analysis of the Tae4-Tai4 interface shows that a helix (α3) of one subunit in dimeric Tai4 plays a major role in binding of Tae4, whereas a protruding loop (L4) in the other subunit is mainly responsible for inhibiting Tae4 activity. The inhibition process requires collaboration between the Tai4 dimer. These results reveal a novel and unique inhibition mechanism in effector-immunity pairs and suggest a new strategy to develop antipathogen drugs.

Introduction

The type VI secretion system (T6SS),4 initially studied in the context of pathogenic bacteria-host interactions, is a complex and widely distributed needle-like protein export machine in Gram-negative bacteria (1). Recently, it has been shown that the T6SS has roles in interspecies interactions by injecting effector proteins into the periplasmic compartment of the recipient cells (2, 3). The T6SS from the opportunistic pathogen Pseudomonas aeruginosa targets at least three effector proteins, namely Tse1, Tse2, and Tse3, to recipient cells. Tse1 has peptidoglycan (PG) amidase activity that hydrolyzes the peptide bond between γ-d-Glu and meso-diaminopimelic acid (mDAP), and Tse3 acts as a muramidase cleaving the β-1,4 linkage between N-acetylmuramic acid and N-acetylglucosamine. The target of Tse2 remains unknown (4, 5). Specific cognate immunity proteins, Tsi1 and Tsi3 from P. aeruginosa, are secreted into the periplasmic space to protect the target cell. These proteins bind and neutralize the activities of Tse1 and Tse3, respectively (3). The effectors and its immunity proteins define a new toxin-antitoxin module.

In 2012, Russell et al. identified new PG peptidase effectors of Gram-negative bacteria that fall into four highly divergent families (Tae1, Tae2, Tae3, and Tae4) on the basis of sequence homology and different substrate specificities (6). Effector and its cognate immunity proteins are often characterized as operons, suggesting that the self-protection is a general feature in Gram-negative bacteria possessing the T6SS. Tse1 and Tsi1 were renamed to Tae1 (type VI amidase effector) and Tai1 (type VI amidase immunity). Tae2 and Tae3 are responsible for the cleavage of a mDAP-d-Ala bond. The opposing cognate immunity proteins, Tai2 and Tai3, inactivate the amidase activities of Tae2 and Tae3. Similar to Tae1, Tae4 can hydrolyze the d-Glu-mDAP bond. However, it targets the acceptor stem rather than the donor stem.

Our group and others have solved the crystal structures Tae1 and its complex with Tai1 from P. aeruginosa and revealed the structural mechanisms for the inhibition of Tae1 by Tai1 (710). But so far the structure of Tae4 has not been reported. Both Tae4 and Tai4 bear very low sequence homology with Tae1 and Tai1, and the effectors have different substrate specificities. Therefore, the substrate recognition and catalysis by Tae4 may be different from that of Tae1. The mechanism of how Tai4 specifically inactivates Tae4 remains unknown. Structural exploration of Tae4 and the Tae4-Tai4 complex will aid the development of new antibacterial agents and our understanding of the role of T6SS in interspecies competition.

In this paper, we have determined the crystal structure of Tae4 from Enterobacter cloacae. The Tae4-Tai4 structures from E. cloacae and Salmonella typhimurium were also solved by x-ray crystallography. Tae4 displays several distinct features different from its structural homologues. A flexible loop may contribute to substrate specificity based on structural and mutagenesis analysis. The Tae4-Tai4 complex forms a heterotetramer that is closely linked to the biological function. A biochemical approach was used to reveal the species specificity of the Tae4 effector recognized by Tai4, and the common nature of the effector inhibited by an immunity protein through binding to a lid loop represents a characteristic toxin-antitoxin interaction model.

EXPERIMENTAL PROCEDURES

Cloning, Expression, and Purification

The genes encoding full-length EcTae4 and truncated EcTai4 (residues 19–117 without the N-terminal 18-residue signal peptide) were amplified from the E. cloacae genomic DNA. The PCR products were digested and then cloned into the pET28at-plus vector (11), introducing an N-terminal His tag followed by a tobacco etch virus cleavage site. These expression plasmids were transformed into Escherichia coli strain BL21 (DE3). EcTae4 was also ligated into the pET21b vector (Novagen) between the NheI and XhoI sites. The two recombinant plasmids (pET21b-EcTae4 and pET28at-plus-EcTai4) were co-transformed into BL21 (DE3) cells for co-expression. The genes encoding full-length StTae4 and truncated StTai4 (without the N-terminal 24-residue signal peptide) were PCR-amplified from S. typhimurium LT2 genomic DNA and cloned using the same procedure as above.

Recombinant proteins were purified as described previously (10). Briefly, the protein expression was induced by adding 0.5 mm isopropyl β-d-thiogalactopyranoside at 289 K. The supernatant was loaded onto a 2-ml Ni-nitrilotriacetic acid resin column (GE Healthcare) and eluted with buffer B (25 mm Tris-HCl, pH 8.0, 50 mm NaCl, 5% v/v glycerol) containing 250 mm imidazole. The proteins were further purified by ion-exchange chromatography and subsequent gel-filtration chromatography. All the mutants were generated by the overlap PCR method.

Crystallization

EcTae4 and the Tae4-Tai4 complex were concentrated to ∼20 mg/ml using Millipore Amicon Ultra 10 KD. Crystallization screens were performed with Hampton Research and Qiagen kits using sitting-drop vapor-diffusion method at 293 K. EcTae4 crystals suitable for x-ray diffraction grew from 0.5 m ammonium sulfate, 0.1 m sodium citrate tribasic dehydrate, pH 5.6, 1.0 m lithium sulfate monohydrate. Tae4-Tai4 from E. cloacae were crystallized using 0.2 m sodium chloride, 0.1 m sodium/potassium phosphate, pH 6.5, 25% (w/v) PEG1000. The SeMet S. typhimurium Tae4-Tai4 crystal was obtained in the mixture solution of 0.2 m ammonium acetate, 0.1 m sodium citrate tribasic dihydrate, pH 5.6, and 30% v/v (+/−) -2-methyl-2,4-pentanediol in 2–3 days.

Data Collection, Structure Determination, and Refinement

All of the data were collected on the beamline 3W1A at BSRF (Beijing Synchrotron Radiation Facility) with a mounted MAR-165 CCD detector. Before data collection, the crystals were soaked in the reservoir solution supplemented with 20% (v/v) glycerol for a few seconds and then flash-frozen in liquid nitrogen.

All the data were processed by HKL2000 (12). The SeMet crystal structure of the Tae4-Tai4 complex from S. typhimurium was determined by the single wavelength anomalous dispersion method. The selenium atoms were located by the program Shelxd (13) and then used to calculate the initial phases in Shelxe. The phases from Shelxe were improved in Resolve (14) and then used in Buccaneer (15) for model building. Coot (16) and Phenix.refine (17) were used for manually building and refinement, respectively. The Tae4 and Tae4-Tai4 complex structures from E. cloacae were determined by molecular replacement using the program Phaser (18) with the SeMet one as the searching model. All of the structures were validated by Molprobity (19).

Small Angle X-ray Scattering (SAXS) and Low Resolution Model Building

SAXS data were collected on the beamline station 1W2A in BSRF using a MARCCD165 detector. The scattering was recorded in the range of the momentum transfer 0.023 < s < 0.22 Å−1, in which s = (4πsinθ)/λ, 2θ represents the scattering angle, and the x-ray wavelength λ is 1.54 Å. The measurements were performed in a cuvette (100 μl) with exposure time of 100 s to diminish the parasitic scattering.

The PRIMUS program was used to process the scattering curves (20). The sample was measured at different protein concentrations (1, 3, and 5 mg/ml for S. typhimurium Tae4-Tai4 proteins; 2, 4, and 6 mg/ml for E. cloacae Tae4-Tai4 proteins) to exclude concentration dependence. The distance distribution functions p (r) was computed with experimental data by the program GNOM (21). The theoretical curves were calculated by the program CRYSOL (22).

The program GASBOR was used to build the ab initio low resolution shapes of the complex in solution (23). The protein structure is represented by an ensemble of dummy residues.

Analytical Ultracentrifugation

The sedimentation velocity measurements were carried out using a Beckman Optima XL-I analytical ultracentrifugation (Beckman-Coulter Instruments) with a Ti rotor at 293 K. Both the Tae4-Tai4 proteins were diluted to an A280 of 0.8. The SEDFIT program was used to analyze the sedimentation coefficient (24).

Surface Plasmon Resonance (SPR) Experiments

The interactions between EcTae4 and EcTai4 were explored using a BIAcore 3000 instrument at 298 K. EcTae4 (∼2 μg/ml) was coupled to a CM5 sensor chip in 10 mm sodium acetate, pH 5.5, using the amine coupling kit. EcTai4, and its mutants were injected at a flow rate of 40 μl/min for 90 s, followed by washing with running buffer (50 mm HEPES, pH 8.0, 150 mm NaCl, and 0.005% (v/v) Tween 20) for 10 min. The CM5 surface was regenerated with 100 mm phosphoric acid at a flow rate of 40 μl/min for 50 s. The kinetic parameters were modeled with the BIAevaluation 4.1 software.

Ligand-Protein Docking

l-Ala-d-Glu-mDAP was docked into the EcTae4 structure by the AutoDock 4.2 program (25). Docking studies were carried out using a Lamarckian genetic algorithm with 25,000 energy evaluations. The grid maps contained 50 × 50 × 50 points with a grid points spacing of 0.375 Å in each dimension. Cys-46 and His-128 were treated as flexible residues in the process of modeling. The model with the lowest binding energy was selected for analysis.

Cell Toxicity Assay

Tae4/Tai4 mutants from E. cloacae were subcloned into the pET22b/pET26b vectors containing signal peptide sequences. A single colony harboring the expressing plasmid was grown in LB medium at 310 K. After overnight culture, the cells were serially diluted in 10-fold steps and plated onto the LB agar supplemented with antibiotic and isopropyl β-d-thiogalactopyranoside. The plates were prepared for pictures after an additional 20 h growth at 310 K.

Protein Pulldown Assay

Tobacco etch virus was used to remove the His tag of the EcTae4 proteins. His-tag EcTai4 and its variant proteins were treated with nickel beads at 277 K for 10 min. Subsequently, the prey proteins were loaded into the beads. After extensive washing with 20 mm imidazole, the proteins were eluted with 250 mm imidazole and analyzed by SDS-PAGE and Coomassie Blue staining.

RESULTS

Overall Structure of Tae4

The crystal structure of Tae4 from E. cloacae (EcTae4) has been determined at a resolution of 2.0 Å. Residues 145–148 could not be seen because of the poor electron density (Fig. 1A). Tae4 crystallizes in the space group P3221 with one molecule in the asymmetric unit (Table 1). The overall structure of Tae4 demonstrates a common architecture of the NlpC/P60 domain (2628), arranged in an ααααββαβαβββ topology. In the present structure, Tae4 can be divided into two subdomains (N-terminal and C-terminal) connected by loop 7 (residues 93–97). The N-terminal subdomain is composed of an antiparallel β-sheet flanked by a short α-helix. The C-terminal subdomain is formed by five α-helices and a β-hairpin (Fig. 1, A and B). According to previous studies, the substrate binding sites are located in a concave between these two subdomains (6, 27) (see Fig. 3A). The Dali server was used to find the structural neighbors to Tae4 (29). There are two CHAP (cysteine, histidine-dependent amidohydrolases/peptidase) family functional proteins with Z-scores greater than 5, including endopeptidase YkfC from Bacillus cereus (PDB ID code 3H41) (30) and bacteriolytic effector Tae1 (Tse1) from P. aeruginosa (PDB ID code 4F0V) (10). Despite the low sequence similarity, superpositions of Tae4 with the two proteins give r.m.s.d. values of 2.720 and 3.068 Å, respectively, suggesting that these structures share the same fold (31) (Fig. 2, A and B).

FIGURE 1.

FIGURE 1.

Structural characteristic of Tae4 and the Tae4-Tai4 complex. A, overall structure of Tae4 with helices in pink, the sheets in dark green, and the loops in light green. The residues from Gly-145 to Gly-148 are without interpretable electron density in the crystal and are connected by dashed lines. The disulfide bond formed between Cys-137 and Cys-141 is shown in orange. Two subdomains (N terminus and C terminus) are connected by loop L7. Two loops L10 and L11 are involved in the catalysis site. B, distribution of conserved residues in Tae4. Conserved residues and variable residues are colored in red and cyan, respectively (33). The catalytic triad Cys-46, His-128, and Asp-139 are shown in stick representation and are highly conserved. C, overall structure of the EcTae4-Tai4 complex. The heterotetramer complex is composed of one Tai4 homodimer (named subunit I (green) and subunit II (blue)), binding two Tae4 molecules (wheat). The protruding loop L4 from Tai4 may inhibit the catalytic activity of Tae4 by interaction with L10. The L11 can be divided into two clip loops. D, overall structure of the StTae4-Tai4 complex composed of one Tae4 (pink) and one Tai4 (green).

TABLE 1.

Data collection and structure refinement statistics

Values in parentheses means those for the highest resolution shell.

Parameters EcTae4-Tai4 StTae4-Tai4 EcTae4
Crystal parameters
    Wavelength (Å) 0.9793 0.9793 0.9793
    Space group C121 P6122 P3221
    Unit cell dimensions a = 91.34, b = 138.14, c = 64.46 Å β = 127.89° a = b = 63.90, c = 365.92 Å a = b = 84.28, c = 43.45 Å

Data collection
    Resolution (Å) 2.10 (2.14–2.10) 2.40 (2.44–2.40) 2.00 (2.03–2.00)
    Number of unique reflections 36,726 (1834) 18,525 (850) 12,215 (593)
    Completeness (%) 100 (100) 99.1 (94.3) 99.1 (98.5)
    Redundancy 7.7 (7.5) 17.6 (12.9) 5.1 (4.8)
    Mean I/σ (I) 34.5 (10.5) 38.1 (4.0) 44.3 (11.1)
    Molecules in asymmetric unit 4 2 1
    Rmerge (%) 6.2 (23.2) 8.2 (43.3) 7.0 (14.2)

Structure refinement
    Resolution range (Å) 23.40–2.10 38.00–2.40 23.29–2.00
    Rwork/Rfree (%) 15.6/20.4 18.7/22.6 20.8/25.3
    Number of atoms
        Residues 515 255 159
        Protein 3948 2004 1239
        Water 477 114 98
    Average B-factor (Å2)
        Main chain (A/B/C/D) 15.90/12.09/15.67/11.90 42.25/35.94 31.63
        Side chain (A/B/C/D) 18.54/16.32/17.95/16.21 45.55/39.95 34.46
        Water 25.47 42.23 37.82
    Ramachandran statistics (%)
        Most favored 98.6 98.8 97.4
        Allowed 1.4 1.2 2.6
    R.m.s.d.
        Bond lengths (Å) 0.007 0.009 0.008
        Bond angles (°) 1.051 1.079 1.120
FIGURE 3.

FIGURE 3.

Catalytic sites of EcTae4 and mutagenesis studies of the key residues involved in substrate binding. A, upper, molecular docking of a peptidoglycan fragment (l-Ala d-Glu-mDAP, yellow stick representation) into the active pocket of EcTae4 shown as the molecular surface representation. A, lower, red dashed lines representing hydrogen bonds formed between the ligand and several residues in EcTae4. B, growth of E. coli in agar plates harboring a vector expressing EcTae4 variants in the periplasm. The cells were prepared with serial 10-fold dilutions from left to right.

FIGURE 2.

FIGURE 2.

Structural comparisons of Tae4 (yellow) with its two homologues YkfC and Tse1. The α2, α3, and L11 in red represent the regions in Tae4 that differ from the two homologues. Asp-124 of EcTae4 and Tyr-89 of Tae1 are shown in stick representation. A, superposition of Tae4 with the NlpC/P60 domain of YkfC. B, superposition of Tae4 with Tae1.

The Potential Active Sites in Tae4

Tae4 hydrolyzes the d-Glu-mDAP bond in the same manner as Tae1. However, unlike Tae1, Tae4 is specific for the non-cross-linked tetrapeptide substrate (6). We have so far been unable to obtain the crystal structure of Tae4 with its substrate. Therefore, molecular docking was employed to investigate the potential binding sites. In the ligand binding model, mDAP forms a hydrogen bond with Asn-19 and is stabilized further by interactions with Asp-139 and Asp-140 at the S1′ site (32). The S1 pocket is shaped by Asn-44, Ala-45 Cys-46, Arg-49, and His-128, where the d-Glu is located (Fig. 3A). In YkfC, Trp-228 is proposed to occupy both S2 and S1 binding sites (30). A similar geometry is also found in Tae4, and the equivalent position is replaced by Lys-43. Sequence alignment of Tae4 with its homologues indicates that most of conserved residues are concentrated around the active cleft (33) (Fig. 1B), especially the S1 and S1′ sites.

Among CHAP family members, the strictly conserved residues cysteine, histidine, and a variable polar residue define the catalytic triad (34). In the case of Tae4, Cys-46 resides in the N-terminal subdomain, whereas His-128 and Asp-139 are located within the C-terminal subdomain (Fig. 1B). Residues clustered around the triad make up a negatively charged patch on the surface of Tae4, although the protein has a predominantly positively charged surface (Fig. 3A, above). To test the role of these residues in substrate recognition, we exploited site-directed mutagenesis and cell growth assay. We discovered that mutants C46A and H128A corresponding to dyad disrupted the amidase activity (Fig. 3B). The third catalytic residue, Cys-110 in Tae1, is not essential for the cleavage of the d-Glu-mDAP bond (8, 9). However, the Asp-139 of Tae4, which is equivalent to the third active site, appears to affect enzyme activity. Therefore, the details of the catalytic mechanism of Tae4 are different from Tae1.

Unlike Tae1 and YkfC, a winding loop (loop 11), rather than the β-sheet, harbors the third catalytic residue in Tae4 (Fig. 2, A and B). This winding loop is linked via the Cys-137–Cys-141 disulfide bond (Fig. 1A). Note that Tae4 is located in the periplasmic space providing an oxidizing environment favorable for the formation of the disulfide bridge. As reported previously, the disulfide bond is observed in Tae1 and provides structural stability (7, 10). This disulfide bridge is also found in the Tae4-Tai4 complex. We tested the activity of C137A and C141A mutant variants. The results showed that the enzymatic activity is significantly reduced in the absence of disulfide bond (Fig. 3B). It is likely that the disulfide bond plays a role in orienting Asp-139 and stabilizing the S1′ binding site.

Intriguingly, part of the winding loop is folded into a shorter turn compared with YkfC and Tae1 in a vertical aspect (Fig. 2, A and B). Taking into consideration that this segment is a spatial neighbor of the active site, we propose that this disordered loop may be relevant to the substrate recognition.

Oligomeric State of the Tae4-Tai4 Complex

The crystal structure of Tae4 in complex with Tai4 from E. cloacae (EcTae4-Tai4) was solved at 2.1 Å resolution and belonged to the C121 space group. There are four molecules in an asymmetric unit. However, the Tae4-Tai4 complex from S. typhimurium (StTae4-Tai4) was crystallized in the P6i22 space group and diffracted to 2.4 Å resolution (Table 1). The asymmetric unit is composed of two molecules.

Both Tae4-Tai4 proteins migrated on size-exclusion chromatography with a molecular mass of ∼49 kDa compared with its calculated heterodimer molecular mass of ∼31 kDa (Fig. 4A, StTae4-Tai4 data not shown). Analytical ultracentrifugation was performed to evaluate the oligomeric state of the complex. The Ec- and St-complex proteins showed a sedimenting boundary at 60.3 and 61.7 kDa, which corresponds to the sedimentation coefficients of 4.12 and 4.19, respectively (Fig. 4B). The result is consistent with the SAXS data. The data in Fig. 4C demonstrate that the experimental SAXS curves are more in agreement with the heterotetramer theoretical curves than the heterodimer curves (data not shown). The ab initio models were carried out to characterize the Tae4-Tai4 complex shape in solution. The available heterotetramer Tae4-Tai4 structures fit well into their respective SAXS-derived low resolution envelopes (Fig. 4C, right upper). Thus, we can conclude that the Tae4-Tai4 complex is a heterotetramer in solution.

FIGURE 4.

FIGURE 4.

Solution behavior of Ec- and StTae4-Tai4 complexes. A, purified EcTae4 (red), EcTai4 (green), and Tae4-Tai4 (blue) complex eluted from gel filtration chromatogram (SuperdexTM 200 10/300 GL) at 18.5, 17.0, and 15.0 ml, respectively. B, sedimentation coefficient distributions of Ec- (upper) and St- (lower) Tae4-Tai4 complexes. C, solution conformation of Ec- (left) and St- (right) Tai4-Tae4 complex by SAXS analysis. Curve 1, experimental data; curve 2, scattering patterns computed from the GASBOR model. Inserts: lower left, P(r) function; upper right, GASBOR models overlapping with heterotetramer crystal structures. The experimental data compare well with the theoretical curves of crystal structure in both Ec- and St- (generated with a symmetry-related molecule) Tai4-Tae4 complex.

The StTae4-Tai4 heterotetramer is generated by crystal packing with symmetry-related molecules (symmetry mate x, x-y, -z+1/6). These two complexes from E. cloacae and S. typhimurium showed a high degree of sequence identity (∼44%). Superposition of these two structures results in an r.m.s.d. value of 3.256 Å (see “Discussion”), suggesting that they share a similar architecture. Consequently, the EcTae4-Tai4 complex is chosen for discussion henceforth, unless otherwise stated.

Dimerization of Tai4

Tai4 is composed of six α-helices, whereas Tai1 displays an all β fold (7, 9). The Tai4 dimerization occurs mainly through the interaction of α2, α3, and α5 of both monomers (Fig. 5A). The conserved residue Asp-54 is involved in extensive hydrogen-bonding interactions with the main chain atoms of Tyr-96, Gln-97, Ile-98, and Leu-99. These are side chain side chain hydrogen bonds in both monomers between Gln-38 and Gln-38, Ser-48 and Asp-47 (Fig. 5B). In addition, there are indirect interactions of several residues such as Asp-47 and Ser-50, Asp-54 and His-95, Asn-106 and Gln-31, via well ordered water molecules by their side chains. The dimer interface is extensive with a buried surface area of 1446 Å2, which is 22.7% of the total surface area per monomer (6346 Å2). In addition, Tai4 behaves as a dimer on the gel filtration column (Fig. 4A), suggesting that Tai4 is a dimer in solution. When mapping the sequence homology onto the Tai4 structure, the most invariant residues are concentrated at the dimer interface, which means that the dimer interactions are conserved across the Tai4 family (Fig. 5C). The Tai4 model was submitted to the Dali server to search against the PDB for its structural homologues (29). The closest structural homologue (the Z-score is 5.4) is Tel2 from Saccharomyces cerevisiae. This protein is involved in chromatin remodeling and PIKK stabilization (35). However, significant differences between these two proteins were observed, such as the oligomeric state, molecular mass, and the arrangement of the helix-turn-helix repeats.

FIGURE 5.

FIGURE 5.

Structural characteristics of the Tai4 homodimer. A, ribbon diagram of EcTai4 with helices drawn as cylinders (subunit I in green and subunit II in blue), adopting the superhelical conformation. B, interaction residues at the interface of the EcTai4 homodimer. C, structure-based sequence alignment of Tai4 from E. cloacae and S. typhimurium. These residues are involved in the interactions with L10, α3, and α5 of Tae4 and Tai4 dimer formation and are indicated below the sequence as a yellow, blue, green, and purple triangle, respectively. D, superposition of EcTai4 with the immunity protein Tsi2 (gray).

Despite low sequence identities, the arrangement of Tai4 is similar to Tsi2 (Fig. 5D). We used a mutagenesis approach to identify the residues important for the dimerization. Like Tsi2, the Tai4 mutant variants have no effects on the dimerization or lead to protein precipitation (4, 5). We postulate that the dimerization is important for the physiological functions, such as inhibition of Tae4.

The Interaction between Tae4 and Tai4

The homodimer of Tai4 can be specified as subunit I (green), which interacts with the N-terminal subdomain of Tae4; and subunit II (blue), which interacts with the C-terminal subdomain of Tae4 (Fig. 6, A and B). The total buried surface area at the interface of the Tai4 dimer with one Tae4 monomer is 966 Å2. The interactions of two helices (α3 and α5) from Tae4 with α3 and α4 from the Tai4 subunit I account for the majority of the interface (668 Å2). The small interface (298 Å2) is created by loops 10 and 11 from Tae4 interacting with loop 4 from the neighboring Tai4 molecule (subunit II). Moreover, there are up to five well ordered water molecules located at the interface which further stabilize the complex.

FIGURE 6.

FIGURE 6.

Recognition of Tae4 by Tai4 in Tai4-Tae4 complex. A and B, the Tae4 makes extensive contacts with Tai4, and the left, middle, and right interfaces are highlighted by frames I, II, and III, respectively. EcTai4 (A) and StTai4 (B) dimer in blue and green are shown as schemes, whereas EcTae4 and StTae4 shown as surface are in wheat and pink, respectively. The catalytic triad cysteine-histidine-aspartate is shown in blue, red, and yellow, respectively. C, close-up views show interactions in frames I, II, and III at the EcTae4-Tai4 interface.

The helix α3 of Tae4 is oriented toward subunit I and interacts with Arg-40 and Glu-74 through hydrogen and salt bonds (Figs. 1C and 6CIII). To validate the interactions at the interface, we introduced point mutations and used SPR to identify the residues required for stable interactions (Table 2 and supplemental Fig. 1). Substitutions R40A and E74A disrupted binding affinity compared with the wild-type Tai4 (WtTai4). The results are in agreement with extensive interactions between the α3 of Tae4 and Tai4. As shown in Fig. 2, A and B, two insertions (α2 and α3) protrude from the N-terminal subdomain compared with Tae1 and YkfC. Although these helices in the apo-Tae4 structure have a high B-factor value, they are well ordered in the holo form (Fig. 7). Furthermore, alignment of these regions results in a higher r.m.s.d. value. These residues involved in the α3 of Tae4 and Tai4 interface are nonconserved (Figs. 1B and 5C). Taken together, the insertions tend to correlate with the species specificity during the Tae4 inhibition by Tai4.

TABLE 2.

Kinetics and affinity constants for wild-type and mutant Tai4 proteins binding to Tae4

Tai4 variants Association rate ka Dissociation rate kd Binding affinity Kd
m11 s1 m
WT 1.29 × 105 3.46 × 10−5 2.69 × 10−10
R40A 3.78 × 105 1.07 × 10−3 2.82 × 10−9
L63A 7.57 × 104 1.45 × 10−3 1.91 × 10−8
E64A 8.36 × 104 1.66 ×10−4 1.98 × 10−9
S66A 2.21 × 105 8.33 × 10−5 3.78 × 10−10
N67A 4.01 × 105 1.04 × 10−4 2.60 × 10−10
L68A 4.48 × 105 1.27 × 10−4 2.83 × 10−10
E74A 1.54 × 105 2.03 × 10−4 1.32 × 10−9
T91A 6.17 × 104 3.77 × 10−4 6.11 × 10−9
FIGURE 7.

FIGURE 7.

B-factor analysis of Tae4 and the Tae4-Tai4 complexes. A, view of the EcTae4 in B-factor putty representation. The flexibility of loop 11 is disordered. Helices α2 and α3, which are involved in the inactions with Tai4, present higher B-factor values. B, B-factor putty representation of the EcTae4-Tai4 heterotetramer. The overall structures of this complex are well ordered. C, B-factor putty representation of StTae4-Tai4 heterodimer. Part of the loop 11 is not visible in the complex structure.

Notably, the residues from Leu-63 to Asn-67 located in α3 and the following loop of Tai4 subunit I form a number of hydrogen bonds with Tae4. The amino group in the main chain of Lys-83 in the α5 from Tae4 directly interacts with hydroxy groups of Glu-64–Asn-67 of Tai4 subunit I (Fig. 6CII). Similarly, the conserved residue Arg-81 of Tae4 forms hydrogen bonds with the main chain atoms of Leu-63 and Leu-68 in Tai4. Additional interactions are found between the strictly conserved residues Val-82 and Glu-64. Substitutions S66A, N67A, and L68A exhibit affinity to Tae4 equal to that of the WtTai4 protein. However, the E64A variant causes a ∼10-fold reduction in affinity, and the Kd value is affected significantly (∼140-fold reduction) by the alanine substitution for leucine at residue 63. This observation indicates that these two residues are important for Tai4-Tae4 recognition. Intriguingly, the equivalent helix of Tsi2 is a crucial segment responsible for binding Tse2 (4). Along with the sequence conservation of these residues in Tae4 and Tai4 (Figs. 1B and 5C), these observations support the idea that the α3 of Tai4 is a major determinant of the Tae4 interaction.

A protruding loop (loop 4) in the Tai4 subunit II also contributes to the hydrogen-bonding network, thereby stabilizing the heterotetramer. The residues Leu-123 and Asp-124 in loop 10, and Ser-151 in the winding loop from Tae4 make direct interactions with Gly-89, Thr-91, and Gly-90 of the protruding loop, respectively (Fig. 6CI). In addition, Gly-89 interacts indirectly with Gly-121 in loop 10 via a water molecule (W145). Because loops 10 and 11 are involved in the formation of the Tae4 catalytic sites, the protruding loop of Tai4 may be closely associated with inhibiting Tae4 enzyme activity.

The Mechanism of Tai4 Inhibits Tae4

The structure of Tae4 in Tae4-Tai4 complex (holo-Tae4) is basically identical to the apo-Tae4 structure (Fig. 8A). Structural alignments of apo-Tae4 with holo-EcTae4 and holo-StTae4 structures give an r.m.s.d. of 0.371 and 0.807 Å, respectively. However, there are clear differences in the C-terminal subdomain (Fig. 8B). The first divergent region is the winding loop, which can be characterized as two clips (Fig. 1C). Clip I, which includes residues from 134 to 144, adopts the same structure in the three forms of Tae4. Residues 145–153 form clip II that folds over the catalytic core. The dominant feature of the winding loop in apo-Tae4 is the second clip portion that is shifted by ∼1.7 and 6.2 Å compared with holo-EcTae4 and holo-StTae4, respectively (Fig. 8B). As mentioned above, part of this clip could not be traced in apo-Tae4 and holo-StTae4 structures because of the higher B-factor (Fig. 9, A and B). Furthermore, Asn-149 in the missing loop is invariant among Tae4 sequences. There is reason to believe that the conformational flexibility of the loop is connected to enzyme activity.

FIGURE 8.

FIGURE 8.

Tsi4 inhibits Tae4 through a protruding loop. A and B, superposition of apo-EcTae4 with the Tae4-Tai4 complex. The major differences between them are the lid loop and the winding loop. C, cell viability assay. Co-expression of Δ86–91-EcTai4 and EcTae4 abolishes inhibition. D, pulldown of the EcTae4 by His-wtEcTai4 and His-Δ86–91-EcTai4. The deletion mutant still has the ability to bind Tae4.

FIGURE 9.

FIGURE 9.

Structures of Tai1 and Tae1-Tai1 complex. A, ribbon representation of Tai1 in rainbow coloration. B, interface between Tae1 and Tai1. The interface is formed primarily by five β-β loops of Tai1 and Tae1 (palecyan surface). The residues Ser-107 and Ser-109 are indicated. The active site Cys-30 and His-91 are show in red and blue, respectively.

Structural alignment of the three Tae4 structures shows that the most prominent difference between apo- and holo-structures is the lid loop (loop 10). Evidently, the lid loop adopts different conformations in the apo- and holo-Tae4 structures (Fig. 8A). In Tae1, Tyr-89 is hypothesized to regulate substrate recognition (9, 10). Asp-124, which is located in the lid loop of Tae4, lies in a similar orientation to Tyr-89 of Tae1, and the carboxyl group of Asp-124 is positioned at the entrance of the substrate binding cleft. However, the D124A variant has no significant effect on cell viability (Fig. 3B).

It is conceivable that the inhibition of Tae4 by Tai4 is not through binding Asp-124 but through a conformational change in the lid loop. Compared with the apo-Tae4 structure, the active pocket is covered by the closed lid loop in both holo structures. Conversely, a positively charged patch in the protruding loop of Tai4 extends from Lys-87 to Thr-91, and could shield the negatively charged patch of the active sites of Tae4. A variant (Δ86–91) lacking 6 residues (Gln-86–Thr-91) of Tai4 was created to investigate its influence on the inhibition of Tae4. In the assays examining cell viability, cells can be rescued by the induced expression of Tai4. As expected, the variant Δ86–91 is not capable of inhibiting amidase activity (Fig. 8C). To further understand the nature of Tae4 inhibition by Tai4, we performed an in vitro His tag pulldown assay. Our results showed that the deletion mutant can still bind to Tae4 (Fig. 8D), excluding the possibility that the heterotetramer disruption impedes the inhibition of Tae4 by Tai4. Further, the tip of the protruding loop is located near the catalytic triad and can make contact with the active site histidine via a water molecule (Fig. 6, A and B). In summary, the inhibition is achieved through insertion of the protruding loop into the pocket and induction of the closed conformation of the lid loop. As a result, the access to the catalytic sites is blocked.

DISCUSSION

The bacteria utilize T6SS and effectors to kill the rival cells. The effector Tae4 is present in the periplasmic space and catalyzes the hydrolysis of PG. Tae4 adopts a canonical papain-like α/β fold and belongs to the N1pC/P60 superfamily of cell wall cysteine peptidases, which are associated with the cell wall hydrolysis and recycling (36, 37). These cell wall peptidases, widely distributed in bacteria, are often characterized by the presence of the auxiliary domain, which functions mainly as a scaffold mediating protein localization (26, 30). The d-glutamyl-l-diamino acid endopeptidase YkfC, for instance, contains two additional SH3b domains (30). However, a single domain is present in Tae1 and Tae4. Gel filtration experiments also revealed that Tae4 behaves as a monomer in solution (Fig. 4A). The characteristic configuration endows Tae1 and Tae4 with extensive and accessible substrate binding surface (Figs. 7, A and B, and 8B) (13). In addition, the effectors can switch one target to another quickly and efficiently due to the loss of the localization process. As a result, both Tae1 and Tae4 show a higher potency with respect to the PG degradation (6, 8).

Although the Tae4 structure is broadly similar to Tae1 structure, Tae4 exhibits two unique features. The first difference is a winding loop, which is involved in substrate binding and hydrolysis. The cleavage of the PG is independent of the third catalytic residue Cys-110, which is buried in the interior of Tae1. However, Asp-139, located in Tae4 winding loop, is solvent-exposed and makes close contacts with His-128 (∼2.7 and 3.0 Å). Asp-139 can be available to stabilize the oxyanion hole. Consistent with these, we found that Asp-139 is an indispensable catalytic residue for the enzyme activity (Fig. 3B). Furthermore, the intact catalytic triad confers higher activities on Tae4 (6, 8). Two helix insertions are the other characteristic profile. Based on structural analysis, the insertions are responsible for defining the species specificity of Tai4 binding to Tae4. In total, the structural variability in Tae1 and Tae4 results from the evolution and renders divergence in substrate recognition.

Tai1 is an all β-sheet protein, whereas Tai4 adopts a superhelical conformation and shows remarkable similarity to the immunity protein Tsi2 from P. aeruginosa (4, 5). The Tae1-Tai1 complex is a heterodimer, but the Tae4-Tai4 complex forms a compact heterotetramer that comprises one Tai4 homodimer binding two Tae4 molecules. The inhibitory mechanism for Tae1 by Tai1 includes a localization event where five β-β loops (βc-βd, βe-βf, βh-βi, βj-βk, and βl-βm) of Tai1 interact with Tae1 (PDB ID code 3VPJ) (Fig. 9A). Previous studies have shown that the insertion of βh-βi loop into the catalytic cleft is critical for inhibition (7, 9). The substrate binding sites are occupied by the βh-βi loop, Ser-107 of which shows a remarkable binding affinity to Tae1. Apart from these, Ser-109 lactated in the βh-βi loop makes direct interaction with the active site His-91 (Fig. 9B). Although both Tae1 and Tae4 are dl-endopeptidases, their immunity proteins work differently from each other. These β-β loops facilitate accurate positioning of Tai1 and match well with the narrow and extended cleft of Tae1. However, the helices of one Tai4 subunit are involved in the Tai4 orientation, and the deep V-shaped groove of Tae4 is not fully occupied by the protruding loop of the other Tai4 subunit. The lid loop of Tae4 serves as a molecular switch to control the PG access to the catalytic pocket. When the protruding loop of Tai4 gets stuck in Tae4, the lid loop is closed, and amidase activity is suppressed. Conversely, the lid loop adopts an open conformation, and Tae4 can reactivate in the absence of the protruding loop. It is worthy to note that the protruding loop of Tai4 participates in both the interaction with the lid loop of Tae4 and the formation of the Tai4 dimer (Figs. 5B and 6C). This protruding loop further contributes to the Tai4 dimer interface through the interaction between Gln-97, Tyr-96, and Asp-54 of both subunits. In other words, the dimerization of Tai4 is required for the protruding loop orientation. As mentioned above, the interaction between Tae4 and Tai4 subunit I is primarily responsible for their interaction. We conclude that the inhibition requires both Tai4 monomers. The distinct inhibitory modes indicate the evolutionary divergence between these two amidase families. It is also suggested that the organisms carrying the Tae1-Tai1 pair compete with that harboring the Tae4-Tai4 pair in nature (6). These hypotheses should be tested in the following studies.

Our studies reveal a novel mechanism of the inhibition of the amidase effector by its cognate immunity protein. To our knowledge, this inhibition mode is first discovered in effector-immunity pairs. These findings will improve our understanding of the T6SS role in interspecies competition and toxin-antitoxin interactions. The significant toxicity of Tae4 and the close relationship between Gram-negative bacteria and pathogenicity make it an attractive target for the antipathogen therapy. We can also develop some small molecule inhibitors or small peptides that bind to Tai4 and inhibit the binding of Tai4 to Tae4 competitively. Without the protection of immunity proteins, the bacteria would suffer toxic effects. The chemical modification of the substrate may be another way for drug discovery.

Supplementary Material

Supplemental Data

Acknowledgments

We thank the staff of the Beijing Synchotron Radiation Facility for assistance in diffraction and SAXS data collections; Yuanyuan Chen and Bingyue Zhou of the Institute of Biophysics, Chinese Academy of Sciences, for the SPR analysis; Xiaoxia Yu of the Institute of Biophysics, Chinese Academy of Sciences, for use of the analytical ultracentrifugation; Huihui Li of the Peking University, School of Life Sciences, for the microscope images; and Dr. Xiang Liu and Zixi Wang for helpful discussion.

*

This work was supported by National Basic Research Program of China Grant 2012CB917203 and National Natural Science Foundation of China Grants 10979005 and 31200552.

Inline graphic

This article contains supplemental Fig. 1.

The atomic coordinates and structure factors (codes 4HFL, 4HFK, and 4HFF) have been deposited in the Protein Data Bank (http://wwpdb.org/).

4
The abbreviations used are:
T6SS
type VI secretion system
CHAP
cysteine, histidine-dependent amidohydrolases/peptidase
mDAP
meso-diaminopimelic acid
PDB
Protein Data Bank
PG
peptidoglycan
r.m.s.d.
root mean square deviation
SAXS
small angle x-ray scattering
SPR
surface plasmon resonance
Tae4
type VI amidase effector 4
Tai4
type VI amidase immunity 4
Tse1
type VI secretion exported 1
Tsi1
type VI secretion immunity 1.

REFERENCES

  • 1. Cambronne E. D., Roy C. R. (2006) Recognition and delivery of effector proteins into eukaryotic cells by bacterial secretion systems. Traffic 7, 929–939 [DOI] [PubMed] [Google Scholar]
  • 2. Hood R. D., Singh P., Hsu F., Güvener T., Carl M. A., Trinidad R. R., Silverman J. M., Ohlson B. B., Hicks K. G., Plemel R. L., Li M., Schwarz S., Wang W. Y., Merz A. J., Goodlett D. R., Mougous J. D. (2010) A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe 7, 25–37 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Russell A. B., Hood R. D., Bui N. K., LeRoux M., Vollmer W., Mougous J. D. (2011) Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475, 343–347 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Li M., Le Trong I., Carl M. A., Larson E. T., Chou S., De Leon J. A., Dove S. L., Stenkamp R. E., Mougous J. D. (2012) Structural basis for type VI secretion effector recognition by a cognate immunity protein. PLoS Pathogens 8, e1002613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Zou T., Yao X., Qin B., Zhang M., Cai L., Shang W., Svergun D. I., Wang M., Cui S., Jin Q. (2012) Crystal structure of Pseudomonas aeruginosa Tsi2 reveals a stably folded superhelical antitoxin. J. Mol. Biol. 417, 351–361 [DOI] [PubMed] [Google Scholar]
  • 6. Russell A. B., Singh P., Brittnacher M., Bui N. K., Hood R. D., Carl M. A., Agnello D. M., Schwarz S., Goodlett D. R., Vollmer W., Mougous J. D. (2012) A widespread type VI secretion effector superfamily identified using a heuristic approach. Cell Host Microbe 11, 538–549 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Benz J., Sendlmeier C., Barends T. R., Meinhart A. (2012) Structural insights into the effector-immunity system Tse1/Tsi1 from Pseudomonas aeruginosa. PLoS ONE 7, e40453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Chou S., Bui N. K., Russell A. B., Lexa K. W., Gardiner T. E., LeRoux M., Vollmer W., Mougous J. D. (2012) Structure of a peptidoglycan amidase effector targeted to Gram-negative bacteria by the type VI secretion system. Cell Rep. 1, 656–664 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Ding J., Wang W., Feng H., Zhang Y., Wang D. C. (2012) Structural insights into the Pseudomonas aeruginosa type VI virulence effector Tse1 bacteriolysis and self-protection mechanisms. J. Biol. Chem. 287, 26911–26920 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Zhang H., Gao Z. Q., Su X. D, Dong Y. H. (2012) Crystal structure of type VI effector Tse1 from Pseudomonas aeruginosa. FEBS Lett. 586, 3193–3199 [DOI] [PubMed] [Google Scholar]
  • 11. Zhang H., Gao Z. Q., Wang W. J., Liu G. F., Shtykova E. V., Xu J. H., Li L. F., Su X. D., Dong Y. H. (2012) The crystal structure of the MPN domain from COP9 signalosome subunit CSN6. FEBS Lett. 586, 1147–1153 [DOI] [PubMed] [Google Scholar]
  • 12. Otwinowski Z., Minor W. (1997) Processing of x-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 [DOI] [PubMed] [Google Scholar]
  • 13. Sheldrick G. M. (2010) Experimental phasing with SHELXC/D/E: combining chain tracing with density modification. Acta Crystallogr. D Biol. Crystallogr. 66, 479–485 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Terwilliger T. C. (2000) Maximum likelihood density modification. Acta Crystallogr. D Biol. Crystallogr. 56, 965–972 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Cowtan K. (2006) The Buccaneer software for automated model building. Acta Crystallogr. D Biol. Crystallogr. 62, 1002–1011 [DOI] [PubMed] [Google Scholar]
  • 16. Emsley P., Lohkamp B., Scott W. G., Cowtan K. (2010) Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Adams P. D., Grosse-Kunstleve R. W., Hung L. W., Ioerger T. R., McCoy A. J., Moriarty N. W., Read R. J., Sacchettini J. C., Sauter N. K., Terwilliger T. C. (2002) PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D Biol. Crystallogr. 58, 1948–1954 [DOI] [PubMed] [Google Scholar]
  • 18. McCoy A. J., Grosse-Kunstleve R. W., Adams P. D., Winn M. D., Storoni L. C., Read R. J. (2007) Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Chen V. B., Arendall W. B., 3rd., Headd J. J., Keedy D. A., Immormino R. M., Kapral G. J., Murray L. W., Richardson J. S., Richardson D. C. (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12–21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Konarev P. V., Volkov V. V., Sokolova A. V., Koch M. H., Svergun D. I. (2003) PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J. Appl. Crystallogr. 36, 1277–1282 [Google Scholar]
  • 21. Svergun D. I. (1992) Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Crystallogr. 25, 495–503 [Google Scholar]
  • 22. Svergun D. I., Barberato C., Koch M. H. (1995) CRYSOL: a program to evaluate x-ray solution scattering of biological macromolecules from atomic coordinates. J. Appl. Crystallogr. 28, 768–773 [Google Scholar]
  • 23. Svergun D. I., Petoukhov M. V., Koch M. H. (2001) Determination of domain structure of proteins from x-ray solution scattering. Biophys. J. 80, 2946–2953 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Schuck P. (2000) Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78, 1606–1619 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Morris G. M., Huey R., Lindstrom W., Sanner M. F., Belew R. K., Goodsell D. S., Olson A. J. (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785–2791 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Anantharaman V., Aravind L. (2003) Evolutionary history, structural features, and biochemical diversity of the NlpC/P60 superfamily of enzymes. Genome Biol. 4, R11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Bateman A., Rawlings N. D. (2003) The CHAP domain: a large family of amidases including GSP amidase and peptidoglycan hydrolases. Trends Biochem. Sci. 28, 234–237 [DOI] [PubMed] [Google Scholar]
  • 28. Rigden D. J., Jedrzejas M. J., Galperin M. Y. (2003) Amidase domains from bacterial and phage autolysins define a family of γ-d,l-glutamate-specific amidohydrolases. Trends Biochem. Sci. 28, 230–234 [DOI] [PubMed] [Google Scholar]
  • 29. Holm L., Kääriäinen S., Rosenström P., Schenkel A. (2008) Searching protein structure databases with DaliLite v. 3. Bioinformatics 24, 2780–2781 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Xu Q., Abdubek P., Astakhova T., Axelrod H. L., Bakolitsa C., Cai X., Carlton D., Chen C., Chiu H. J., Chiu M., Clayton T., Das D., Deller M. C., Duan L., Ellrott K., Farr C. L., Feuerhelm J., Grant J. C., Grzechnik A., Han G. W., Jaroszewski L., Jin K. K., Klock H. E., Knuth M. W., Kozbial P., Krishna S. S., Kumar A., Lam W. W., Marciano D., Miller M. D., Morse A. T., Nigoghossian E., Nopakun A., Okach L., Puckett C., Reyes R., Tien H. J., Trame C. B., van den Bedem H., Weekes D., Wooten T., Yeh A., Hodgson K. O., Wooley J., Elsliger M. A., Deacon A. M., Godzik A., Lesley S. A., Wilson I. A. (2010) Structure of the γ-d-glutamyl-l-diamino acid endopeptidase YkfC from Bacillus cereus in complex with l-Ala-γ-d-Glu: insights into substrate recognition by NlpC/P60 cysteine peptidases. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 66, 1354–1364 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Krissinel E., Henrick K. (2004) Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr. D Biol. Crystallogr. 60, 2256–2268 [DOI] [PubMed] [Google Scholar]
  • 32. Schechter I., Berger A. (1967) On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157–162 [DOI] [PubMed] [Google Scholar]
  • 33. Landau M., Mayrose I., Rosenberg Y., Glaser F., Martz E., Pupko T., Ben-Tal N. (2005) ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res. 33, W299–302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Aramini J. M., Rossi P., Huang Y. J., Zhao L., Jiang M., Maglaqui M., Xiao R., Locke J., Nair R., Rost B., Acton T. B., Inouye M., Montelione G. T. (2008) Solution NMR structure of the NlpC/P60 domain of lipoprotein Spr from Escherichia coli: structural evidence for a novel cysteine peptidase catalytic triad. Biochemistry 47, 9715–9717 [DOI] [PubMed] [Google Scholar]
  • 35. Takai H., Xie Y., de Lange T., Pavletich N. P. (2010) Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes. Genes Dev. 24, 2019–2030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Park J. T., Uehara T. (2008) How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol. Mol. Biol. Rev. 72, 211–227 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Smith T. J., Blackman S. A., Foster S. J. (2000) Autolysins of Bacillus subtilis: multiple enzymes with multiple functions. Microbiology 146, 249–262 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Data

Articles from The Journal of Biological Chemistry are provided here courtesy of American Society for Biochemistry and Molecular Biology

RESOURCES